Lv61
3050 积分 2022-07-31 加入
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
8天前
已完结
Atypical signaling, ligand recognition and selective agonist discovery of complement receptor C5aR2
9天前
已完结
Hypofractionated Radiotherapy Induces ISG15+MHC-I+ Neutrophils to Augment Anti-Tumor Immunity and Prime Immune Checkpoint Blockade Responses in Rectal Cancer
17天前
已完结
Natural killer cells infiltrating colorectal cancer and MHC class I expression
5个月前
已完结
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
5个月前
已完结
Advances in mechanisms, combined therapeutic strategies and dual-target inhibitors for synergistic antitumor effects of HDAC and PD-1/PD-L1 pathway
5个月前
已关闭
Autophagy as a target for anticancer therapy
6个月前
已完结
Autophagy and autophagy-related pathways in cancer
6个月前
已完结
PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients
6个月前
已完结
皖公网安备34019202002308
